Cancer / Immunology
Hexvix® Completes Phase III Bridging Trial Enrollment for Bladder Cancer
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
July 10, 2023 | News
GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs
Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...
July 07, 2023 | News
I-Mab Publishes Givastomig, a Claudin18.2 x 4-1BB Bispecific Antibody, in JITC
Givastomig is engineered to bind to CLDN18.2-expressing cancer cells and co-stimulatory receptor 4-1BB on adjacent T cells, with the aim of activating...
July 06, 2023 | News
FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer
FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...
July 05, 2023 | News
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China
The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...
July 05, 2023 | News
Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development
Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...
June 29, 2023 | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology
By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...
June 29, 2023 | News
INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data
INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...
June 28, 2023 | News
CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.
The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...
June 27, 2023 | News
Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...
June 26, 2023 | News
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The licen...
June 23, 2023 | News
Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data at SNMMI
Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...
June 23, 2023 | News
SeekIn paves the way for cancer early detection in low- and middle-income countries
The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...
June 19, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
